Vaccination programs in schools to improve access for underserved communities in Colorado
School-Located Vaccination to Reduce Inequities in Vaccination Uptake Among Historically Excluded Populations in Colorado
This study is all about making it easier for kids under 11 in Colorado, especially those from communities that often face challenges, to get their COVID-19 vaccinations right at school, so they don’t have to worry about transportation or clinic hours.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project ID | NIH-10942634 on NIH RePORTER |
What this research studies
This research focuses on implementing school-located vaccination programs to address barriers faced by historically excluded populations in Colorado, particularly for children under 11 years old. By utilizing School-Based Health Centers and School-Located Vaccine Clinics, the project aims to provide easier access to COVID-19 vaccinations for students who may struggle to receive immunizations in traditional healthcare settings. The approach includes organizing vaccination events at schools, which can help overcome logistical challenges such as transportation and clinic hours. The study will evaluate the effectiveness of these programs in increasing vaccination rates among underserved communities.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years from minoritized racial/ethnic groups or those living in underserved rural areas.
Not a fit: Patients who are not within the age range of 0-11 years or those who have access to traditional healthcare services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase vaccination rates among children in underserved populations, thereby improving public health outcomes.
How similar studies have performed: Previous vaccination programs in schools have shown success in improving immunization rates, particularly during the H1N1 pandemic, indicating that this approach is both tested and effective.
Where this research is happening
Santa Monica, United States
- Rand Corporation — Santa Monica, United States (Active)
Researchers
- Principal investigator: Gromis, Ashley — Rand Corporation
- Study coordinator: Gromis, Ashley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.